Late-onset infections and granuloma formation after facial polylactic acid (New-Fill) injections in women who are heavy smokers

Plastic and Reconstructive Surgery

Volumn 124, Issue 1, 2009, Pages 316-317

  Azizzadeh, Babak ^a  

^a Center for Facial and Nasal Plastic Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYLACTIC ACID;

AWARENESS; CLINICAL ASSESSMENT; DERMIS; GRANULOMA; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; INJECTION SITE INFECTION; LETTER; LIPOATROPHY; MOUTH FLORA; PRIORITY JOURNAL; REJUVENATION; RISK BENEFIT ANALYSIS; RISK REDUCTION; SKINFOLD; SMOKING; WOUND HEALING; WRINKLE;

BACTERIAL INFECTIONS; CELLULOSE; COSMETIC TECHNIQUES; FEMALE; GRANULOMA, FOREIGN-BODY; HUMANS; INJECTIONS; LACTIC ACID; MANNITOL; SMOKING; TIME FACTORS;

EID: 68249110082     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3181a83772     Document Type: Letter

References (5)

1. Sculptra (prescribing information). Berwyn, Pa.: Dermik Laboratories; 2006.
2. Lowe NJ. Dispelling the myth: Appropriate use of poly-L-lactic acid and clinical considerations. J Eur Acad Dermatol Venereol. 2006;20:2-6.
3. Vleggaar D, Bauer U. Facial enhancement and the European experience with Sculptra (poly-l-lactic acid). J Drugs Dermatol. 2004;3:542-547.
4. Lowe NJ, Maxwell CA, Patnaik R. Adverse reactions to dermal fillers: Review. Dermatol Surg. 2005;31:1616-1625.
5. Freiman A, Bird G, Metelitsa AI, Barankin B, Lauzon GJ. Cutaneous effects of smoking. J Cutan Med Surg. 2004;8:415-423.